Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

117.93
Delayed Data
As of Jun 14
 +0.69 / +0.59%
Today’s Change
92.56
Today|||52-Week Range
141.86
+21.13%
Year-to-Date
3 Cheap Drug Stocks You Can Buy Right Now
Jun 16 / MotleyFool.comFOO - Paid Partner Content
3 Drug Stocks That Could Win From Key FDA Approvals in June
Jun 04 / MotleyFool.comFOO - Paid Partner Content
Is Alexion (ALXN) a Solid Growth Stock? 3 Reasons to Think " Yes "
Jun 06 / Zacks.comZAK - Paid Partner Content
 

Today’s Trading

Previous close117.24
Today’s open117.34
Day’s range116.77 - 118.97
Volume981,564
Average volume (3 months)1,393,589
Market cap$26.4B
Data as of 4:00pm ET, 06/14/2019

Growth & Valuation

Earnings growth (last year)-82.40%
Earnings growth (this year)+19.13%
Earnings growth (next 5 years)+14.00%
Revenue growth (last year)+17.00%
P/E ratio63.7
Price/Sales5.29
Price/Book2.88

Competitors

 Today’s
change
Today’s
% change
REGNRegeneron Pharmaceut...-2.18-0.71%
INCYIncyte Corp+1.34+1.75%
AGNAllergan-5.08-4.20%
BMRNBiomarin Pharmaceuti...-1.52-1.85%
Data as of 4:00pm ET, 06/14/2019

Financials

Next reporting dateJuly 29, 2019
EPS forecast (this quarter)$2.33
Annual revenue (last year)$4.1B
Annual profit (last year)$77.6M
Net profit margin1.88%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Ludwig N. Hantson
Chief Financial Officer &
Executive Vice President
Paul J. Clancy
Corporate headquarters
Boston, Massachusetts

Forecasts